Royalty Pharma PLC (Class A) Live Stock Price Today, Share Analysis and Chart

Name: Royalty Pharma plc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Royalty Pharma plc - Ordinary Shares - Class A
Rating: 2.038277875
Author: Trendlyne DVM scores

Momentum Trap

about

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products...

53.40 0.15 (0.28%)

New 52W High today

3.5M

XNAS Volume

XNAS 14 May, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Royalty Pharma PLC (Class A) is on 19 May 2026 for the purpose of RBC Capital Markets 2026 Global Healthcare Conference See details

Low Financial Strength

27.8 / 100

Mid Valuation

40.7 / 100

Technically Moderately Bullish

66.8 / 100

Momentum Trap These stocks have average financials but are currently seeing momentum. Investors should exercise caution in buying these stocks View Similar Embed DVM

1Yr Price target upside is 11%

8 analysts

Royalty Pharma PLC (Class A) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Royalty Pharma PLC (Class A) Live Stock Price Today, Share Analysis and Chart

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products...

New 52W High today

SWOT Analysis

Royalty Pharma PLC (Class A) Live Price Chart